Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH details

Primary information
ID	antitb_1432,
Name	197067
N-Terminal modification	Viomycin
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	R1=H, R2= >C=CHNHCONH2, R3=Tbd (Tuberactin)
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Cell Line	MIC = 1.6 Î¼g/ml
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),

Primary information
ID	antitb_1433,
Name	197067
N-Terminal modification	Tuberactinomycin
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	R1 = OH, R2= >C=CHNHCONH2, R3 = Tbd (tuberactidine)
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Cell Line	MIC = 3.1 Î¼g/ml
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),

Primary information
ID	antitb_1434,
Name	197067
N-Terminal modification	Tuberactinomycin O
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	R1 = H, R2 = >C=CHNHCONH2, R3 =Cpd (Capreomycidine)
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Cell Line	MIC = 1.6 Î¼g/ml
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),

Primary information
ID	antitb_1435,
Name	197067
N-Terminal modification	Dihydroviomycin
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	None
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Cell Line	MIC = 6.2 Î¼g/ml
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),

Primary information
ID	antitb_1436,
Name	197067
N-Terminal modification	Tetrahydroviomycin
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	R1 = H, r2 = >CH-OH, R3=Tbd(Tuberactidine)
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Cell Line	MIC = 3.1 Î¼g/ml
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),

Primary information
ID	antitb_1437,
Name	197067
N-Terminal modification	Oxoviomycin
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	R1= H, R2 = > c=o, R3 = Tbd (Tuberactidine)
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),

Primary information
ID	antitb_1438,
Name	197067
N-Terminal modification	Broxoviomycin
C-Terminal Modification	H2N-CH-CH-CH-CH-R1-CH-NH2-Ch-CO-Nh-C-CO-NH-CH2OH-CO-NH-CH(CH2OH)-CO-NH-R2-CO-R3-HN-CH
Chemical Modification	Free
Linear/Cyclic	Free
Length	R1 = H, r2 = >CH-OH, R3=Tbd(Tuberactidine)
Nature	38
Inhibition Concentration	Mycobacterium tuberculosis
In Vitro/ In vivo	Mycobacterium tuberculosis 607
Cell Line	MIC = 800 Î¼g/ml
Inhibition Concentration	in vitro
Sequence	1977
Cytotoxicity	NA
In vivo Model	NA
Lethal Dose	NA
Immune Responce	NA
Mechanism of Action	NA
Target	NA
Combination Therapy	NA
Other activities	NA
PMID	NA
Year of Publication	Antibacterial against Bacillus subtilis, Pseudomonas aeruginosa, proteus vulgaris, satphylococus aureous
Tertiary Structure (Technique)	Not Predicted),